
Lapatinib 250 mg Tablet is a targeted anticancer medicine used mainly for HER2-positive breast cancer, often in combination with other therapies. It works by blocking HER2 and EGFR proteins that promote cancer cell growth.
| Manufacturer | Samarth Life Sciences Pvt Ltd |
| Generic Name | Lapatinib |
| Strength | 250mg |
| Pack size | 30 Tablets |
| Used For | HER2-positive breast cancer |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Saudi Arabia, Qatar, Kuwait, and many other countries. |

Authentic Medicines

Fast Delivery

Secure Payment

24/7 Support
| Package | USD | GBP | AUD | PHP | TND | KRW | RON | HKD | MYR | THB | SGD | AED | SAR | QAR | KWD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30 Tablets | $130 | £96 | A$181 | ₱8,150 | د.ت378.43 | ₩174,083 | lei 589 | HK$1,019 | RM529 | ฿4,293 | S$165 | د.إ477.49 | ر.س488.15 | ر.ق473.33 | د.ك39.650 |
Lapatinib is a targeted therapy that blocks HER2 and EGFR receptors on cancer cells. These receptors send signals that promote tumor growth. By blocking them, Lapatinib slows or stops cancer cell multiplication.
Dr. Ashish Kumar holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His areas of interest include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout treatment.
Disclaimer
All information on this website is for educational purposes only. Medicines should be used only with a doctor’s prescription and supervision. We do not provide medical advice, and product details may change without notice. Always consult a healthcare professional before using any medication.